Form 4 Tracker
Beam Therapeutics Inc.
BEAM

36 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 31, 2026Apr 1 10:32 PMJohn M. EvansDirector, CEO
Sale
25,000$22.76$569.1K986,667(D)

View →

Mar 30, 2026Apr 1 10:32 PMJohn M. EvansDirector, CEO
Sale
25,000$22.37$559.2K986,667(D)

View →

Apr 2, 2026Mar 31 8:33 PMCHRISTINE BELLON
Proposed Sale
20,000$21.90$438.0K—

View →

Apr 2, 2026Mar 31 8:29 PMGIUSEPPE CIARAMELLA
Proposed Sale
26,250$21.90$574.9K—

View →

Apr 2, 2026Mar 31 8:22 PMAMY SIMON
Proposed Sale
20,000$21.90$438.0K—

View →

Apr 2, 2026Mar 31 8:19 PMJOHN M. EVANS
Proposed Sale
66,874$21.90$1.5M—

View →

Mar 31, 2026Mar 31 8:16 PMJOHN M EVANS
Proposed Sale
25,000$22.76$569.1K—

View →

Mar 30, 2026Mar 30 9:28 PMJOHN M EVANS
Proposed Sale
25,000$22.37$559.2K—

View →

Feb 24, 2026Feb 26 9:05 PMGiuseppe CiaramellaPresident
Sale
35,000$32.00$1.1M190,216(D)

View →

Feb 24, 2026Feb 24 9:15 PMGIUSEPPE CIARAMELLA
Proposed Sale
35,000$32.00$1.1M—

View →

Jan 30, 2026Feb 2 9:05 PMJohn M. EvansDirector, CEO
Sale
25,000$28.36$708.9K986,667(D)

View →

Jan 29, 2026Feb 2 9:05 PMJohn M. EvansDirector, CEO
Sale
25,000$29.38$734.6K986,667(D)

View →

Jan 30, 2026Jan 30 9:04 PMJOHN M EVANS
Proposed Sale
25,000$28.36$708.9K—

View →

Jan 29, 2026Jan 29 9:01 PMJOHN M EVANS
Proposed Sale
25,000$29.38$734.6K—

View →

Jan 22, 2026Jan 26 9:05 PMBethany J CavanaghSVP, Finance and Treasurer
Sale
6,198$35.00$216.9K34,813(D)

View →

Jan 22, 2026Jan 26 9:05 PMChristine BellonChief Legal Officer
Sale
1,371$34.00$46.6K95,667(D)

View →

Jan 22, 2026Jan 22 9:03 PMCHRISTINE BELLON
Proposed Sale
1,371$34.00$46.6K—

View →

Jan 20, 2026Jan 21 9:05 PMBethany J CavanaghSVP, Finance and Treasurer
Sale
3,034$30.12$91.4K41,011(D)

View →

Jan 15, 2026Jan 20 9:05 PMChristine BellonChief Legal Officer
Sale
18,629$34.61$644.8K97,038(D)

View →

Jan 15, 2026Jan 15 11:00 PMCHRISTINE BELLON
Proposed Sale
18,629$34.61$644.8K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 16, 2026Oct 17 12:09 AMJohn M. EvansDirector, CEO
Option Exercise
25,000$1.03155,804(D)

View →

Oct 15, 2026Oct 17 12:09 AMJohn M. EvansDirector, CEO
Option Exercise
25,000$1.03180,804(D)

View →

Jun 30, 2026Jul 1 8:05 PMJohn M. EvansDirector, CEO
Option Exercise
25,000$1.03205,804(D)

View →

Jun 29, 2026Jul 1 8:05 PMJohn M. EvansDirector, CEO
Option Exercise
25,000$1.03230,804(D)

View →

Jun 17, 2026Jun 22 8:05 PMGiuseppe CiaramellaPresident
Option Exercise
35,505$1.0356,946(D)

View →

Jun 3, 2026Jun 5 8:05 PMChristi ShawDirector
Grant/Award
19,676$29.5519,676(D)

View →

Jun 3, 2026Jun 5 8:05 PMKathleen E WalshDirector
Grant/Award
19,676$29.5519,676(D)

View →

Jun 3, 2026Jun 5 8:05 PMJohn MaraganoreDirector
Grant/Award
19,676$29.5519,676(D)

View →

Jun 3, 2026Jun 5 8:05 PMMark FishmanDirector
Grant/Award
19,676$29.5519,676(D)

View →

Jun 3, 2026Jun 5 8:05 PMChirfi GuindoDirector
Grant/Award
19,676$29.5519,676(D)

View →

Jun 3, 2026Jun 5 8:05 PMGraham K CooperDirector
Grant/Award
19,676$29.5519,676(D)

View →

Mar 31, 2026Apr 1 10:32 PMJohn M. EvansDirector, CEO
Option Exercise
25,000$0.6718,672(D)

View →

Mar 30, 2026Apr 1 10:32 PMJohn M. EvansDirector, CEO
Option Exercise
25,000$0.6743,672(D)

View →

Feb 24, 2026Feb 26 9:05 PMGiuseppe CiaramellaPresident
Option Exercise
35,000$17.00397,313(D)

View →

Jan 31, 2026Feb 2 9:05 PMBethany J CavanaghSVP, Finance and Treasurer
Grant/Award
40,000$27.6240,000(D)

View →

Jan 31, 2026Feb 2 9:05 PMGiuseppe CiaramellaPresident
Grant/Award
80,000$27.6280,000(D)

View →

Jan 31, 2026Feb 2 9:05 PMSravan Kumar EmanyChief Financial Officer
Grant/Award
63,500$27.6263,500(D)

View →

Jan 31, 2026Feb 2 9:05 PMChristine BellonChief Legal Officer
Grant/Award
40,000$27.6240,000(D)

View →

Jan 31, 2026Feb 2 9:05 PMJohn M. EvansDirector, CEO
Grant/Award
180,000$27.62180,000(D)

View →

Jan 30, 2026Feb 2 9:05 PMJohn M. EvansDirector, CEO
Option Exercise
25,000$0.6768,672(D)

View →

Page 1 of 2

Next →